| Metric | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Total liabilities and stockholders' equity | $601.9M | $644.9M | $638.6M | $719.9M | $809.3M | $905.2M | $1.4B | $2.0B |
| Total stockholders' equity | $540.2M | $553.1M | $567.9M | $618.2M | $681.6M | $781.4M | $1.3B | $1.8B |
| Additional paid-in capital | $676.1M | $698.4M | $717.3M | $738.4M | $765.2M | $801.6M | $1.2B | $1.6B |
| Common stock | 8K | 1B | 1B | 1B | 1B | 1B | 1B | 1B |
| Shares Outstanding | $106.5M | $131.1M | $197.1M | $283.6M | $162.8M | $295.1M | $476.3M | $288.5M |
| Retained earnings | -$135.3M | -$144.9M | -$149.1M | -$119.8M | -$83.2M | -$19.8M | $62.9M | $220.0M |
| Common Stock Shares Issued | 164.3M | 166M | 167.2M | 169.7M | 171.2M | 172.9M | 178.5M | 184.2M |
| Share-Based Payment Award Options Outstanding - Number | 6.4M | 5.6M | 5.1M | 4.2M | 3.5M | 2.8M | 2.5M | 2.3M |
| Accumulated other comprehensive income (loss) | -$519.0K | -$375.0K | -$310.0K | -$403.0K | -$437.0K | -$428.0K | -$632.0K | $2.1M |
| Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $9.0K | $9.0K | $9.0K |
| Weighted Average Exercise Price of Outstanding Options | $1.97 | $2.00 | $2.01 | $2.14 | $2.23 | $2.20 | $2.19 | $2.22 |
| Common Stock Par Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |